<tt id="6hsgl"><pre id="6hsgl"><pre id="6hsgl"></pre></pre></tt>
          <nav id="6hsgl"><th id="6hsgl"></th></nav>
          国产免费网站看v片元遮挡,一亚洲一区二区中文字幕,波多野结衣一区二区免费视频,天天色综网,久久综合给合久久狠狠狠,男人的天堂av一二三区,午夜福利看片在线观看,亚洲中文字幕在线无码一区二区
          USEUROPEAFRICAASIA 中文雙語Fran?ais
          China
          Home / China / China

          Interest in TCM growing globally

          By Shan Juan | China Daily | Updated: 2013-03-27 07:14

          Chinese mainland accounts for 2% of herbal medicine sales worldwide

          While some Chinese scholars propose abolishing traditional Chinese medicine, foreign pharmaceutical institutions and industries are pursuing them.

          More than 100 countries and regions around the world have set up TCM institutions, with the United States, Europe, Japan and South Korea investing heavily in related research and medication development, industry, analyses show.

          The UK-based pharmaceutical company GlaxoSmithKline PLC announced its first TCM medication research and development program, which targets not just the Chinese market, but the global one as well.

          "TCM is a well-established medical science based on thousands of years of clinical practices. It shows great promise treating complicated conditions that the single-target Western medicine has failed to handle," said Zang Jingwu, senior vice-president and head of GlaxoSmithKline's R&D in China.

          "Our priority is to transform TCM from an experience-based practice to evidence-based medicines through innovation and differentiation," he said.

          Currently, a 10-person team in Shanghai is in charge of the program, with a medication candidate for skin disease in the works.

          Zang, a US-trained neurologist, said TCM is more of a multi-target therapeutical approach, which might work to treat complex conditions.

          He said an example of this is ginkgo biloba leaf extract, approved in Germany, which, according to China's pharmacopeia, is TCM in essence. Globally, ginkgo biloba leaf extract is widely used to treat dizziness and ringing in the ears.

          Industry insiders call such products "exotic TCM". In ancient TCM works, ginkgo is known for restoring consciousness.

          "That is similar to our approach in TCM R&D," he said. He referred to skin diseases for which medications can demonstrate more evidence of effectiveness as a top candidate for TCM. Other areas of research that also show great promise include stomach and intestinal diseases and supplementary treatments for cancer, he added.

          However, given that the culture and ideology of TCM is different from that of Western medicine, great innovation is required to integrate the two sciences, he said.

          "In fact, many in Western medicine circles have recognized the importance of TCM, but the problem is how to prove and develop that," said Huang Jianyin, deputy secretary-general of the World Federation of Chinese Medicine Societies.

          TCM is developed through empirical testing and refinement of herbal mixtures and relies on clinical experience, and many in the West don't trust that, he said. TCM, particularly herbal products, are largely available in the US and Europe, but questions like how to prove their effectiveness in the context of Western medicine and how to best use them remain unanswered, Zang added.

          Zhang Lingping, director of the international cooperation department of the Beijing University of Chinese Medicine, welcomed the emerging trend.

          "Their increasing interest shows Western medicine circles have begun to learn about the time-honored medical science, which originated in China," she said. Zhang said traditionally, Western medicines have been highly targeted and such a method doesn't seem to work well for complex diseases.

          "They are beginning to closely look at TCM, which highlights a natural and comprehensive manner in healing," she said.

          The university also had partnerships with foreign academic institutions in TCM research focusing on cancer and cardio-cerebrovascular diseases.

          A better approach for TCM development is to enhance its dosage and stability, she said.

          "It's more feasible and practical for them to improve the techniques during the TCM production, which the multinational pharmaceutical giants are better at," she said.

          But that might also pose a challenge for domestic TCM industries, she acknowledged.

          Of the global herbal medicine sales volume, the Chinese mainland accounted for only 2 percent, industry analyses show. Japan has the share of the market at 90 percent.

          Mao Zedong once expected TCM and Chinese cuisine would be China's two major contributions to the world, said Huang. "He wouldn't have imagined the tough situation today."

          shanjuan@chinadaily.com.cn

          Editor's picks
          Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
          License for publishing multimedia online 0108263

          Registration Number: 130349
          FOLLOW US
          主站蜘蛛池模板: 99久久免费只有精品国产| 69天堂人成无码免费视频| 色欲国产精品一区成人精品| 久久国产免费观看精品3| 思思99思思久久最新精品| 中文字幕乱妇无码AV在线| 亚洲永久精品免费在线看| 亚洲欧洲日产国无高清码图片| 亚洲AV成人无码久久精品四虎| 无码精品国产d在线观看| 91超碰在线精品| 亚洲伊人久久综合精品| 性夜久久一区国产9人妻| 国产jizz中国jizz免费看| 国产视频一区二区在线看| 自拍偷自拍亚洲精品情侣| 永久免费无码成人网站| 精品国产成人国产在线视| 热久久国产| 欧美日韩一线| 国产超碰无码最新上传| 久久精品国产99国产精品严洲| 亚洲天堂伊人久久a成人| 久久夜色精品国产爽爽| 午夜福利视频| 亚洲国产日韩a在线亚洲| 久久精品国产福利一区二区| 国产精品av免费观看| gay片免费网站| 亚洲人成网站18禁止无码| 一本色道久久88综合日韩精品| 亚洲综合久久国产一区二区| 国产成人av免费观看| 熟妇的味道hd中文字幕| 韩国18禁啪啪无遮挡免费| 国产精品日韩av在线播放| 日本高清在线播放一区二区三区 | 日韩精品无码免费专区网站| 国产欧美综合在线观看第十页 | 国产av黄色一区二区三区| 欧美一区二区三区欧美日韩亚洲|